Skip to content

Effect of Narikela lavana in Amlapitta (hyperacidity)

A Clinical Study on the Management of Amlapitta with Narikela Lavana

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017741
Enrollment
30
Registered
2019-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

Intervention1: Narikela lavana 1gms thrice daily before food with go ghrita (cows ghee) QS for 14 days: This classical medicine is explained in Rasatarangini (14/123-129). It includes Narikela (Cocus

Sponsors

Dean Faculty of Ayurved Parul University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of non ulcer dyspepsia according to Rome III criteria Patients of Amlapitta showing symptoms Udarashoola,udaragurutwam, Amlodgara, hrd-kanta daha, hrllasa, klama with chronicity not more than one month.

Exclusion criteria

Exclusion criteria: evidence of internal bleeding/ulcer like hematemesis, malena etc under gastric irritant drugs like aspirin, antacids etc metabolic disorders like diabetes mellitus, hypertension, hyperthyroidism pregnancy & lactation Alcoholic & habitual smoker

Design outcomes

Primary

MeasureTime frame
Symptoms of Amlapitta such as Udarashoola, Udara Gurutva, Tikta Amla Udgara, Hrit Kantha Daha, Hrillas, Klama and Utklesha according to Gastro Intestinal Symptom Rating Scale (GSRS)Timepoint: Symptoms of Amlapitta accessed at baseline and at the interval of 7 days till the end of 14 days

Secondary

MeasureTime frame
Assessment of quality of life according to Quakity of Life In Reflux and Dyspepsia (QoLRAD)Timepoint: Accessed at the interval of each 7 days till the end of 14 days

Countries

India

Contacts

Public ContactDr Mamta B

Parul Institute of Ayurved, Parul university

bmamta732@gmail.com9979873433

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026